About NeuroVision
NeuroVision is a company based in Sacramento (United States) founded in 2010 by Steven Verdooner.. NeuroVision has raised $31.6 million across 8 funding rounds from investors including Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery. The company has 13 employees as of December 31, 2022. NeuroVision offers products and services including BrainHealth.net and Afina™ Retinal Imaging. NeuroVision operates in a competitive market with competitors including Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others.
- Headquarter Sacramento, United States
- Employees 13 as on 31 Dec, 2022
- Founders Steven Verdooner
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurovision Imaging, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.6 M (USD)
in 8 rounds
-
Latest Funding Round
- Investors
-
Employee Count
13
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroVision
NeuroVision offers a comprehensive portfolio of products and services, including BrainHealth.net and Afina™ Retinal Imaging. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for screening and managing cognitive health services
AI tool for detecting amyloid in retina related to Alzheimer's
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroVision
NeuroVision has successfully raised a total of $31.6M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(15 Jul 2013)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series C - NeuroVision | Valuation |
investors |
|
| Feb, 2021 | Amount | Series C - NeuroVision | Valuation |
investors |
|
| May, 2018 | Amount | Series C - NeuroVision | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroVision
NeuroVision has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funds are managed to support unlisted companies' growth.
|
Founded Year | Domain | Location | |
|
Drugs for Alzheimer's prevention, treatment, and cure are discovered.
|
Founded Year | Domain | Location | |
|
VSP Vision is engaged in providing comprehensive eye care solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroVision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroVision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurovision Comparisons
Competitors of NeuroVision
NeuroVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| domain | founded_year | HQ Location |
Neurological disorders are diagnosed using eye-tracking assessment tools.
|
|
| domain | founded_year | HQ Location |
Micro-navigation systems for stroke surgery are developed.
|
|
| domain | founded_year | HQ Location |
Eye-tracking solutions for vision assessment and treatment are provided.
|
|
| domain | founded_year | HQ Location |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| domain | founded_year | HQ Location |
Developer of neurodiagnostic techniques
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurovision
Frequently Asked Questions about NeuroVision
When was NeuroVision founded?
NeuroVision was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is NeuroVision located?
NeuroVision is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Who is the current CEO of NeuroVision?
Steven Verdooner is the current CEO of NeuroVision. They have also founded this company.
Is NeuroVision a funded company?
NeuroVision is a funded company, having raised a total of $31.6M across 8 funding rounds to date. The company's 1st funding round was a Series C of $11.2M, raised on Jul 15, 2013.
How many employees does NeuroVision have?
As of Dec 31, 2022, the latest employee count at NeuroVision is 13.
What does NeuroVision do?
NeuroVision was founded in 2010 in Sacramento, United States, within the neuroscience sector. Diagnostic tests and biomarkers for early detection of amyloid pathology in Alzheimers disease are developed by the company. Retinal imaging technology called Afina is utilized for visualization and measurement of retinal health. Datasets are aggregated, analyzed through biostatistics, and processed with machine learning algorithms to predict neurodegenerative diseases.
Who are the top competitors of NeuroVision?
NeuroVision's top competitors include NovaSight, iota Biosciences and Tobii Dynavox.
What products or services does NeuroVision offer?
NeuroVision offers BrainHealth.net and Afina™ Retinal Imaging.
Who are NeuroVision's investors?
NeuroVision has 8 investors. Key investors include Johnson & Johnson Innovative Medicine, HHS, Alzheimer's Drug Discovery, VSP Vision, and Johnson & Johnson Innovation.